Risks of Taking Weight Loss Supplements

Translate to Spanish or other 102 languages!

 GLP-1 medications are continuing to grow in popularity, but not everyone is eligible for them. As a result, some are opting to take weight-loss supplements instead, which doctors warn can be unsafe. Image for illustration purposes
 GLP-1 medications are continuing to grow in popularity, but not everyone is eligible for them. As a result, some are opting to take weight-loss supplements instead, which doctors warn can be unsafe. Image for illustration purposes
- Advertisement -

CLEVELAND CLINIC – GLP-1 medications are continuing to grow in popularity, but not everyone is eligible for them. As a result, some are opting to take weight-loss supplements instead, which doctors warn can be unsafe. 

“The problem with supplements is that they are not standardized. GLP-1 medications have been rigorously tested in multiple randomized controlled trials in large cohorts of patients. So, what that means is, they have been tried on multiple patients before they have been deemed safe,” said Peminda Cabandugama, MD, endocrinologist at Cleveland Clinic. 

Dr. Cabandugama said unlike GLP-1 medications, weight-loss supplements do not need to be approved for use by the FDA.

- Advertisement -

That means anything can be added to them, including harmful or illegal ingredients. 

Not to mention, there’s no way to know the potential side effects or long-term risks of taking them. 

Another concern with weight-loss supplements is how they interact with other medications. 

“These supplements could interact with other medications you’re taking, and this can be disastrous if you’re taking any sort of life-saving medication,” Dr. Cabandugama said.

- Advertisement -

If you are currently taking a weight-loss supplement, it’s important to let your physician know because they can offer safer alternatives. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

Physicians Warn of Rising ER Visits Linked to E-Bikes and Scooters

Mega Doctor News CLEVELAND CLINIC - As electric bikes and scooters grow in...

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.
- Advertisement -